KMT2C and breast cancer: The comparison of the mutational frequency of these driver genes between primary and metastatic tumors showed that, in ER+ metastatic breast cancers, the mutational frequency of ESR1, TP53, NF1, AKT1, KMT2C, and PTEN genes was higher than in primary breast cancers [47].